Dopamine autoreceptor reserve in vitro: Possible role of dopamine D3 receptors

European Journal of Pharmacology

Volumn 305, Issue 1-3, 1996, Pages 119-122

  Aretha, Cheryl Wiley ^b   Galloway, Matthew P ^a,b  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7 OH DPAT (7 hydroxy N,N di n propyl 2 aminotetralin); dopamine D3 receptor; receptor reserve

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2 ETHOXY 1(2H) QUINOLINECARBOXYLIC ACID ETHYL ESTER; 3 HYDROXYBENZYLHYDRAZINE; APOMORPHINE; BROMOCRIPTINE; DOPA; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE AUTORECEPTOR; FORSKOLIN; RECEPTOR RESERVE;

ALKYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN SLICE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; MALE; NONHUMAN; OLFACTORY NUCLEUS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029994003     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00142-2     Document Type: Article

References (18)

1. 3-preferring ligands act at synthesis modulating dopamine autoreceptors, J. Pharmacol. Exp. Ther. 274, 609.
2. Burris, K.D., M.A. Pacheco, T.M. Filtz, M.P. Kung, H.F. Kung and P.B. Molinoff, 1995, Lack of discrimination by agonists for D-2 and D-3 dopamine receptors, Neuropsychopharmacology 12(4), 335.
3. Bohmaker, K., T. Puza, M. Goldstein and E. Meller, 1989, Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum, J. Pharmacol. Exp. Ther. 248, 97.
4. Clark, D., R.S. Salah and M.P. Galloway, 1991, Differential agonist profile of the entantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine, Synapse 8, 169.
5. 3 autoreceptor-mediated effects?, Pharm. Biochem. Behav., 52(2), 275.
6. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical, and nigrostriatal pathways. J. Pharmacol. Exp. Ther., 275(2), 899.
7. 3 receptors, Eur. J. Pharmacol. 272, R1.
8. Hamblin, M.W. and I. Creese, 1983, Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycobonyl-2-ethoxy-1,2-dihydroquinoline, Life Sci. 32, 2247.
9. Haycock, J.W. and D.A. Haycock, 1991, Tyrosine hydroxylase in rat brain dopaminergic nerve terminals, J. Biol. Chem. 266(9), 5650.
10. 3 receptor sites in rat brain: a comparative study using in situ hybridization histochemistry and ligand binding autoradiography, Eur. J. Neurosci. 5, 145.
11. Levant, B., 1995, Differential sensitivity of «H-3»7-OH-DPAT-labeled binding-sites in rat-brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, Brain Res. 698, 146.
12. 3 receptors, Eur. J. Pharmacol. 278, 243.
13. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. USA 89, 8155.
14. 3 receptors, Eur. J. Pharmacol. 249, R5.
15. Meller, E., E. Helmer-Matyjek, K. Bohmaker, C.H. Adler, A.J. Friedhoff and M. Goldstein, 1986, Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists, Eur. J. Pharmacol. 123, 311.
16. Salah, R.S., D.M. Kuhn and M.P. Galloway, 1989, Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices, J. Neurochem. 52, 1517.
17. 2 receptor functionally coupled to adenylyl cyclase in chinese hamster ovary cells, J. Pharmacol. Exp. Ther. 48, 344.
18. Wolf, M.E., M.P. Galloway and R.H. Roth, 1986, Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices, J. Pharmacol. Exp. Ther. 236(3), 699.